Sign in Subscribe
Platform SCUBA

November 2025 SCUBA Platform Update

November 2025 SCUBA Platform Update

If October felt like a systems check, November felt like a divergence point.

Platform vendors are growing headcount while ABA providers are slowing or contracting. Hiring gains were modest, but the direction was consistent:

platforms are investing into 2026 even as Medicaid pressure, payor friction, and margin compression shape provider behavior.

This raises an important question:

Why are platforms accelerating when providers are bracing?

Possibilities include:

  • Confidence that Medicaid pressure won’t meaningfully reduce demand for operational tooling.
  • Recognition that tightening margins may increase the need for automation, not reduce it.
  • Investment in AI, integration, and value-based readiness, where workflow data becomes a differentiator.
  • Rising payor complexity pushing clinics toward external automation partners rather than additional administrative staff.

Against that backdrop, here are the new signals that mattered in November:

✅ Platform Milestones & New Signals

  • EarliPoint Diagnostics - CEO Jamie Pagliaro highlighted the new Netsmart partnership, aimed at bringing early-diagnosis and outcomes tracking into whole-person care infrastructure. Also added Cortica (top-35) to its client base, indicating continued enterprise traction.
  • Rethink launched a bi-directional integration with Raintree, positioning Rethink as the ABA/behavioral module inside Raintree’s rehab EHR/RCM stack—allowing PT/OT/SLP groups to expand into ABA without replacing their core system. Rethink also expanded content distribution through Netsmart, embedding training and educational resources across Netsmart’s human-services ecosystem.
  • At AIS East, Anonymous Health indicated it is building an AI-driven intake agent with an API-first design, and exploring potential use in autism/ABA intake and verification workflows.
  • Also at AIS East, LinusBio announced they are developing a hair-strand–based autism biomarker test (FDA Breakthrough designation). Science is intriguing, though the commercial pathway and provider adoption strategy remain early.
  • Artemis announced AI-powered session notes, joining the broader wave of automated clinical documentation tools across the ABA tech landscape.

🧪 SCUBA Dataset Refreshed

This month’s update includes:

  • U.S. headcount
  • Job postings
  • Top-35 provider traction
  • Investment history
  • ABA market focus
  • Capterra / G2 ratings

Together, these indicators show where platforms are expanding, consolidating, or diversifying as economic pressure reshapes autism care.

👂 Feedback Welcome

As always, I welcome updates, corrections, or new platform milestones from the field.
Your insights help keep this dataset accurate and valuable for operators, vendors, and investors across the autism ecosystem.

👉 Subscribe to the ABA Mission Newsletter for regular insights into ABA strategy, tech platforms, and investment activity.
🔗 Sign up here

Read next